Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
KENTOR ERIC S
   2. Issuer Name and Ticker or Trading Symbol
ENDOCARE INC [ENDO] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O ENDOCARE, INC., 201 TECHNOLOGY DRIVE		 3. Date of Earliest Transaction (Month/Day/Year)
01/08/2008
(Street)

IRVINE, CA 92618		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) (2) 01/08/2008   A   1,707.05     (3)   (3) Common Stock 1,707.05 (4) 1,707.05 D  
Restricted Stock Units (5) (2) 01/10/2008   A   2,060.74     (5)   (5) Common Stock 2,060.74 (4) 2,060.74 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
KENTOR ERIC S
C/O ENDOCARE, INC.
201 TECHNOLOGY DRIVE
IRVINE, CA 92618		   X      

Signatures

 /s/ Clint B. Davis, as attorney-in-fact   01/10/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Granted under the Company's Non-Employee Director Deferred Stock Unit Program. The deferred stock units covered by this Form 4 represent director fees earned during the quarter ended December 31, 2007, which Mr. Kentor elected to receive in the form of deferred stock units instead of cash.
(2) Each deferred stock unit and each restricted stock unit reflects the right to receive one share of common stock in the future, subject to the terms and conditions of the programs under which such units are granted.
(3) The DSU "payout date" is the earlier of (i) January 4, 2011, or (ii) as soon as administratively practicable following Mr. Kentor's separation from service (but in no event earlier than December 31, 2008).
(4) Not applicable.
(5) Granted pursuant to the automatic grant provisions in effect under the Company's Non-Employee Director Restricted Stock Unit Program, under the Company's 2004 Stock Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock units on January 10, 2009 and the related shares will be issued upon Mr. Kentor's separation from service, subject to acceleration in the case of a Change in Control or Corporate Transaction, as such terms are defined in the 2004 Stock Incentive Plan.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.